Second-line treatment of hepatocellular carcinoma: from theory to practical issues

by V. V. Breder, K. K. Laktionov
Published 2019-12-01

Anemiya pri zlokachestvennykh opukholyakh

by V V Breder, V A Gorbunova, N S Besova
Published 2002-09-01

Immunotherapy for hepatocellular cancer: beginning and future perspectives

by M. A. Kazantseva, V. V. Breder, K. K. Laktionov
Published 2019-06-01

Preliminary results of retrospective analysis Atezolizumab and Bevacizumab in first-line therapy of advanced HCC

by I. А. Dzhanyan, М. V. Natrusova, V. V. Breder
Published 2021-06-01

PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS

by V. V. Breder, K. K. Laktionov, M. I. Davydov
Published 2017-11-01

HEPATOCELLULAR CARCINOMA AS A SOCIAL AND MEDICAL PROBLEM IN THE RUSSIAN FEDERATION

by V. V. BREDER, V. Y. KOSYREV, N. E. KUDASHKIN, K. K. LAKTION
Published 2016-12-01

Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case

by Yu V Bisovskaya, V V Breder, B M Medvedeva, V A Gorbunova
Published 2014-06-01

Immunotherapy for small-cell lung cancer

by A. Ye. Kuzminov, K. K. Laktionov, A. A. Yegorova, V. V. Breder, T. D. Barbolina
Published 2019-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

by V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Published 2020-07-01

Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy

by K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder
Published 2020-12-01

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment

by A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov
Published 2020-07-01

Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

by K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov
Published 2019-12-01

Fibrolamellar liver cancer: the modern concept

by E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov
Published 2020-12-01

A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma

by K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova
Published 2018-07-01

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started

by V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov
Published 2018-07-01

Intrahepatic cholangiocarcinoma

by A. B. Luk’yanchenko, B. M. Medvedeva, M. A. Shabanov, E. R. Virshke, V. V. Breder, K. A. Romanova
Published 2016-02-01

Pseudoprogression in patients on immunotherapy

by D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Published 2019-06-01

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

by K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba
Published 2019-06-01

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION

by К. К. LAKTIONOV, М. V. PEREGUDOVA, V. V. BREDER, E. V. REUTOVA, D. A. PEREGUDOV, M. S. ARDZINBA, P. A. CHERNENKO, D. T. MARINOV
Published 2016-12-01

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

by K. K. Laktionov, V. V. Breder, D. I. Yudin, K. A. Sarantseva, L. V. Laktionova, M. S. Ardzinba, E. V. Reutova, A. V. Egorova
Published 2019-12-01